Your browser doesn't support javascript.
loading
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders.
Wu, Xuewei; Yang, Xiaobao; Xiong, Yan; Li, Ruitong; Ito, Takahiro; Ahmed, Tamer A; Karoulia, Zoi; Adamopoulos, Christos; Wang, Hong; Wang, Li; Xie, Ling; Liu, Jing; Ueberheide, Beatrix; Aaronson, Stuart A; Chen, Xian; Buchanan, Sean G; Sellers, William R; Jin, Jian; Poulikakos, Poulikos I.
Afiliação
  • Wu X; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Yang X; Department of Pharmacological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Xiong Y; Department of Pharmacological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Li R; The Broad Institute of Harvard and MIT, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Ito T; The Broad Institute of Harvard and MIT, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Ahmed TA; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Karoulia Z; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Adamopoulos C; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Wang H; Eli Lilly and Company, Indianapolis, IN, USA.
  • Wang L; Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC, USA.
  • Xie L; Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC, USA.
  • Liu J; Department of Pharmacological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Ueberheide B; Department of Biochemistry and Molecular Pharmacology, New York University, New York, NY, USA.
  • Aaronson SA; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Chen X; Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC, USA.
  • Buchanan SG; Eli Lilly and Company, Indianapolis, IN, USA.
  • Sellers WR; The Broad Institute of Harvard and MIT, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
  • Jin J; Department of Pharmacological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Poulikakos PI; Department of Oncological Sciences, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Poulikos.poulikakos@mssm.edu.
Nat Cancer ; 2(4): 429-443, 2021 04.
Article em En | MEDLINE | ID: mdl-34568836

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Nat Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido